Grand Pharmaceutical Group Limited

Grand Pharmaceutical Group Limited is a leading international pharmaceutical company dedicated to advancing healthcare through technological innovation. Specializing in pharmaceutical technology, nuclear medicine for anti-tumor diagnosis and treatment, cerebro-cardiovascular precision intervention, diagnosis and treatment technology, and biotechnology, Grand Pharmaceutical Group Limited is committed to improving patient outcomes and contributing to a healthier society.

With headquarters in Wuhan, Hubei, China, at 武汉沌口经济开发区车程北路2号, 武汉, 湖北 430000, CN, and an additional location in 北京市麦子店街盛福大厦, 北京, 北京 100000, CN, Grand Pharmaceutical Group Limited operates with over 30 member companies. The group concentrates on critical pharmaceutical areas, including respiratory and severe disease anti-infection, oncology, cerebro-cardiovascular emergencies, ophthalmology, cerebro-cardiovascular precision intervention diagnosis and treatment, nuclear medicine anti-tumor solutions, and high-quality amino acids. Grand Pharmaceutical Group Limited adapts to market developments and focuses on technological innovation as a driving force.

Grand Pharmaceutical Group Limited distributes innovative pharmaceutical products and medical devices across global markets, including the United States, Australia, Germany, and Belgium. Collaborations with world-leading pharmaceutical enterprises, universities, and research institutions diversify the product pipeline in the medical therapeutic field. With 5 R&D technology platforms and 9 R&D centers worldwide, Grand Pharmaceutical Group Limited remains at the forefront of pharmaceutical advancements. We invite the management team at Grand Pharmaceutical Group Limited to create a customized and exclusive company showcase and product listing on our platform, enhancing your market presence and growth opportunities.